OGI

Organigram Global Inc.

Organigram Global Inc. (OGI) is rated C (2.5/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Value (B); its weakest is Momentum (C-).

Quantitative Factor Evaluation • Updated

Overall Rating
2.5 / 5.0
C
Value
B
Factor Score 3.2 / 5.0
Growth
C-
Factor Score 2.1 / 5.0
Profitability
C+
Factor Score 2.5 / 5.0
Momentum
C-
Factor Score 1.9 / 5.0
Revisions
C+
Factor Score 2.6 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio 1.9
EV / EBITDA 12.7
Rev Growth YoY 49.4%
Gross Margin 36.5%
Price Return 3M -32.2%
Price Return 12M -49.1%
Catalyst Signal 0.00
Market Cap $117.6M
TTM Revenue $309.2M
Price / Sales 0.4
ROE 17.6%

Historical Factor Score Progression

Date Value Growth Profitability Momentum Revisions Overall
2026-11-13 B (3.2) C- (2.1) C+ (2.5) C- (1.9) C+ (2.6) C (2.5)
2026-11-06 B (3.2) C (2.2) C+ (2.6) C (2.3) C+ (2.7) C+ (2.6)
2026-10-30 B (3.3) C (2.2) C+ (2.6) C (2.3) C+ (2.7) C+ (2.6)
2026-10-23 B (3.2) C (2.2) C+ (2.6) C (2.3) C+ (2.6) C+ (2.6)
2026-10-16 B (3.2) C (2.2) C+ (2.6) C (2.3) C+ (2.6) C+ (2.6)
Page 1 of 4